140 likes | 279 Views
t uberculosis - the opportunity in our lifetime . Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium. the achievements. GF funding provided TB treat to 9.7 mil people Contributed to increase of the case detection from 43% to 65%
E N D
tuberculosis - the opportunity in our lifetime Dr. Lucica Ditiu | Executive Secretary | Stop TB Partnership 09.April.2013 | Brussels, Belgium
the achievements GF funding provided TB treat to 9.7 mil people Contributed to increase of the case detection from 43% to 65% and treatment success from 67% to 87% in the 22 high burden countries
the achievements
the burden TB incidence Belgium Global / 100k 8 / 100k 125 107 92 79 68 58 50 43 37 32 28 24 20 18 15 13 11 10 9 8 year 1990 2000 2010 2020 2030 2040 2050 2060 2070 2080 2090 2100 2110 2120 2130 2140 2150 2160 2170 2180 2190 2200 2210 2230 2250
the burden 1.1 MILLION 1.4 MILLION People who died of TB in 2011 Population of Brussels
the burden 1.4 MILLION People who died of TB in 2011
9 MILLION estimated TB cases the burden MDR-TB 570,000 estimated cases that go undiagnosed & untreated • 59,000 MDR-TB cases diagnosed and treated 1.4 MILLION 6 MILLION cases diagnosed and treated
the lessons learned 25x 1.5 MILLION 25 fold increase cases detected & treated due to prioritized interventions in vulnerable populations doubled detection & treatment through engagement with TB communities lives saved due to TB & HIV integration (2005-2011)
the potential & tools • Cost effective • TB interventions are the 4th most cost effective among interventions to control disease (Copenhagen Consensus 2012) • Cost per DALY gained varies between US$ 5-200 for first line treatment and US$ 90-365 for second line treatment • Costs are being driven down: diagnostics and second line drugs • New tools • Gene Xpert: new rapid diagnosis for TB and Rif resistance rolled out (1,000 machine worldwide) • First new anti-TB drug in 50 years • New drug regimens for shorter treatment duration and fewer pills in clinical trials • 12 vaccine candidates in the pipeline • Strategic investment guidance • Sustainable outlook with strong co-investment from countries • Potential of mobilizing up to 60% of financial needs from domestic resources • Opportunity to leverage domestic commitments
with the tools and expertise we have today we must accelerate our efforts and investments for tomorrow
9 MILLION estimated TB cases with the vision MDR-TB 630,000 diagnosed and treated 570,000 estimated cases that go undiagnosed & untreated • 59,000 MDR-TB • cases diagnosed and treated 1.4 MILLION MILLION cases diagnosed and treated 6 7 8 9 cases diagnosed and treated
the impact Potential lives saved with treatment TB MDR-TB TB/HIV potential lives saved with full funding through 2016 6 MILLION
9 MILLION estimated TB cases with the vision MDR-TB 630,000 diagnosed and treated a world free of TB 9 MILLION cases diagnosed and treated